KB
Katapally Bhavani
About Katapally Bhavani
Data last updated:
Katapally Bhavani is a Director at Srineon Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Srineon Pharmaceuticals Private Limited reported revenue of ₹1.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Srineon Pharmaceuticals Private Limited U46497TS2023PTC179201 | Director | 20 Nov 2023 | 2023 | ₹1.5 Lakh (FY 2025) | Active |
Board colleagues of Katapally Bhavani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Voruganti Shivani | 10398467 | Srineon Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Katapally Bhavani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Katapally Bhavani
Katapally Bhavani currently holds 1 directorship: Srineon Pharmaceuticals Private Limited (Director, since 20 Nov 2023, revenue ₹1.5 Lakh (FY 2025)).
Katapally Bhavani was first appointed on 20 Nov 2023 as Director at Srineon Pharmaceuticals Private Limited.
The current boards of Katapally Bhavani's companies include Voruganti Shivani (Srineon Pharmaceuticals Private Limited).